These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis]. Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767 [No Abstract] [Full Text] [Related]
7. Letter: Chemotherapy of Hodgkin's disease. Winokur SH N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438 [No Abstract] [Full Text] [Related]
8. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease. De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720 [No Abstract] [Full Text] [Related]
9. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
10. Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy. Frei E; Luce JK JAMA; 1973 Jan; 223(2):166-8. PubMed ID: 4739456 [No Abstract] [Full Text] [Related]
11. The treatment of Hodgkin's disease. Fairley GH Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820 [No Abstract] [Full Text] [Related]
12. Status and perspectives in chemotherapy of Hodgkin's disease. Frei E Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436 [No Abstract] [Full Text] [Related]
14. Splenectomy effects on chemotherapy in Hodgkin's disease. Panettiere F; Coltman CA Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035 [No Abstract] [Full Text] [Related]
15. Long term remissions with combined modality therapy for advanced Hodgkin's disease. Prosnitz LR; Farber LR; Fischer JJ; Bertino JR; Fischer DB Cancer; 1976 Jun; 37(6):2826-33. PubMed ID: 949702 [TBL] [Abstract][Full Text] [Related]
16. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
17. Long term experience with combination chemotherapy in advanced Hodgkin's disease. Garrett MJ; Das S; Smith JD; Freedman LS Clin Oncol; 1977 Jun; 3(2):145-54. PubMed ID: 68843 [No Abstract] [Full Text] [Related]
18. The use of different drugs and combinations in the treatment of Hodgkin's disease. Fairley GH Ser Haematol; 1973; 6(2):196-201. PubMed ID: 4784374 [No Abstract] [Full Text] [Related]
19. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients]. Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520 [No Abstract] [Full Text] [Related]
20. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy. Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037 [No Abstract] [Full Text] [Related] [Next] [New Search]